| Ovarian Hyperstimulation Syndrome Using Calcium Infusion (NCT05198128) | Al-Azhar University | 2022-03-01 |
| Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy (NCT05588635) | Centre Hospitalier Régional Metz-Thionville | 2019-11-01 |
| Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS (NCT03996434) | ClinAmygate | 2019-07-01 |
| Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome (NCT05638529) | Mount Sinai Hospital, Canada | 2019-05-01 |
| Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response (NCT04351126) | Ganin Fertility Center | 2019-04-01 |
| Montelukast for Prevention & Treatment of OHSS (NCT03794037) | Benha University | 2018-12-05 |
| Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders (NCT04797338) | Assaf-Harofeh Medical Center | 2017-12-29 |
| The Influence of Timing of Cabergoline Initiation on Prevention of OHSS (NCT02620605) | Mona M Shaban | 2017-12-20 |
| Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET (NCT03071172) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2017-03-01 |
| Preventive Application of GnRH Antagonist on Early OHSS (NCT03188471) | First Affiliated Hospital, Sun Yat-Sen University | 2017-01-01 |
| The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome (NCT03876145) | Royan Institute | 2016-11-12 |
| Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome (NCT02846493) | Sun Yat-sen University | 2016-08-01 |
| Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response (NCT02701452) | University Hospital, Lille | 2016-02-26 |
| Medical Assistance for the Procreation and Risk of Thrombosis. (NCT02610608) | University Hospital, Brest | 2016-02-02 |
| Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS) (NCT02392520) | Eugonia | 2015-05-01 |
| Monitoring the Early Follicular Phase With Androstenedione in Low-dose Step-up Ovulation Induction in High Responders (NCT02329483) | Bagcilar Training and Research Hospital | 2014-12-01 |
| Study of Serum Levels of Oxidative Stress Markers in Ovarian Hyperstimulation Patients (NCT02202278) | Karadeniz Technical University | 2014-06-01 |
| Long Acting GnRH Antagonist in PCOS Women Undergoing IVF (NCT02084940) | Bioroma | 2014-03-01 |
| The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes (NCT01979341) | Antalya IVF | 2013-10-01 |
| Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS (NCT02200952) | San Carlo Public Hospital, Potenza, Italy | 2013-06-30 |
| Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS (NCT01815138) | UConn Health | 2013-03-01 |
| Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome? (NCT01714648) | Elisha Hospital | 2012-11-01 |
| GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome (NCT01268761) | Instituto Valenciano de Infertilidad, IVI VALENCIA | 2012-04-01 |
| Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers (NCT01535859) | KK Women's and Children's Hospital | 2012-04-01 |
| Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation (NCT01606709) | UConn Health | 2012-04-01 |
| Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS (NCT02670304) | First Affiliated Hospital, Sun Yat-Sen University | 2012-01-01 |
| Freeze All Strategy Versus Fresh Embryo Transfer After GnRH Analogue Trigger (NCT05362734) | Istituto Clinico Humanitas | 2012-01-01 |
| Endometrial Receptivity After GnRH Agonist Triggering (NCT01500863) | IVI Madrid | 2011-11-01 |
| Calcium for Prevention of Ovarian Hyperstimulation Syndrome (NCT01427335) | Cairo University | 2011-10-01 |
| Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome (NCT01014104) | Royan Institute | 2009-10-01 |
| Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program (NCT01009567) | Royan Institute | 2009-06-01 |
| The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors (NCT00867659) | Virginia Center for Reproductive Medicine | 2009-03-01 |
| Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS (NCT01477970) | Iakentro Fertility Centre | 2009-02-01 |
| Short Versus Long Protocol for IVF and IVF+ICSI (NCT00756028) | Peter Hornnes, MD, DMSc | 2009-01-01 |
| Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist (NCT00835523) | University Hospital Schleswig-Holstein | 2008-05-01 |
| Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome (NCT00665041) | Instituto Valenciano de Infertilidad, IVI VALENCIA | 2008-05-01 |
| Ovarian Hyperstimulation Syndrome and Cabergoline (NCT01569256) | Etlik Zubeyde Hanim Womens' Health and Teaching Hospital | 2008-03-01 |
| The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome (NCT00617864) | Yale University | 2007-09-01 |
| Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide (NCT00329693) | Ferring Pharmaceuticals | 2006-06-01 |
| 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists" (NCT00119925) | Radboud University Medical Center | 2005-10-01 |
| The Use of GnRH Agonist Trigger in the Prevention of OHSS (NCT00349258) | University of Connecticut | 2004-08-01 |
| Cabergoline Reduces OHSS (NCT00440258) | Instituto Valenciano de Infertilidad, IVI VALENCIA | 2004-04-01 |
| Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients (NCT00417144) | Eugonia | 2003-11-01 |
| Transfer of Fresh Versus Frozen/Thawed Embryos in IVF Cycles Where GnRH Agonist is Utilized for Oocyte Maturation. (NCT00365027) | HaEmek Medical Center, Israel | |
| In Vitro Maturation of Immature Oocytes (NCT00480337) | Sheba Medical Center | |